GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
HealthCare Global Enterprises Ltd

HealthCare Global Q2 FY27 Revenue up 16% YoY to INR 7,318 Mn

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 05 Nov 2026, 08:44 PM IST  ·  BSE ID: f9432113-65d3-4844-b214-27ae44b51fe0
View Original BSE Filing (PDF)
💡
In Simple Terms
HealthCare Global's latest financial results show its revenue grew 16% to INR 7,318 Mn in Q2 FY27.
🤖 AI Summary
  • HealthCare Global reported Q2 FY27 revenue of INR 7,318 Mn, reflecting 16% year-over-year growth.
  • Adjusted EBITDA for Q2 FY27 increased 17% year-over-year to INR 1,425 Mn, achieving a 19.7% margin.
  • Operational highlights include 9% YoY growth in patient volumes and a 7% increase in Average Revenue Per Patient (ARPP).
  • Company added 25 operational beds in Q2 FY27, contributing to a total of 146 bed additions in H1 FY27.
  • Adjusted PAT for Q2 FY27 was INR 192 Mn, with a decline of 9% YoY primarily due to a prior period tax adjustment.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue (Q2 FY27)
7,318 Mn
16%
Adjusted EBITDA (Q2 FY27)
1,425 Mn
17%
Adjusted EBITDA Margin (Q2 FY27)
19.7%
Profit before Tax (Q2 FY27)
301 Mn
Adjusted PAT (Q2 FY27)
192 Mn
-9%
Volume (Q2 FY27)
82,405
9%
ARPP (Q2 FY27)
88,805
7%
Operational Beds Added (H1 FY27)
146 Beds
🏢 How This Affects the Company
📈
Business Impact
The company's revenue growth, driven by volume and ARPP increases, indicates expansion across its South, West, and East regions, as well as international business. Advanced technology deployments and new clinical programs aim to enhance service offerings and market position.
💰
Financial Impact
Revenue increased to INR 7,318 Mn in Q2 FY27, and Adjusted EBITDA grew to INR 1,425 Mn, with margins improving to 19.7%. Adjusted PAT of INR 192 Mn reflects a YoY decline influenced by a one-time deferred tax adjustment in the prior year.
⚙️
Operational Impact
Capacity expanded with 25 new operational beds in Q2 FY27, including locations in Kenya, Kolkata, and Nagpur. New MR-LINAC, LINAC, and cardiac robotic surgery systems were operationalized, alongside the introduction of CAR-T cell therapy and advanced diagnostics.
⚠️
Risk Impact
The provision towards wage revision under the Karnataka Wage Act partially impacted margin expansion. Start-up losses from the North Bangalore facility continue to be accounted for.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, specifically the 16% YoY revenue growth and 17% YoY Adjusted EBITDA growth in Q2 FY27.
🔍
Management Signal
Management is signaling continued focus on revenue growth, margin improvement, capacity expansion, and the adoption of advanced medical technologies and clinical programs.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — observe sustained revenue and EBITDA growth.
Updates on North Bangalore facility performance and start-up loss reduction.
Further developments in advanced therapy adoption and capacity expansion plans.
LOW RISK No new significant risks were disclosed. Current impacts like wage revisions and startup losses are being managed.
💡 Investor Takeaway
HealthCare Global reported Q2 FY27 consolidated revenue of INR 7,318 Mn, up 16% YoY. Adjusted EBITDA increased 17% YoY to INR 1,425 Mn, with a margin of 19.7%. Patient volumes grew 9% YoY, and ARPP rose 7% YoY, confirming operational improvements and business expansion.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue grew by 16% YoY to INR 7,318 Mn in Q2 FY27, with Adjusted EBITDA growing 17% YoY to INR 1,425 Mn.
  • Adjusted EBITDA margin improved to 19.7% in Q2 FY27 from 19.2% in Q2 FY26, driven by revenue quality.

⚠️ Concerns

  • Adjusted PAT declined by 9% YoY to INR 192 Mn in Q2 FY27, reflecting a favourable one-time deferred tax adjustment in Q2 FY26.
  • Margin expansion was partially impacted by a provision for wage revisions under the Karnataka Wage Act and North Bangalore start-up losses of INR 61 Mn.
📅 Company Track Record
HealthCare Global's Q1 FY27 Adjusted PAT was up 190% YoY to INR 138 Million. Prior filings also indicated the deployment of INR 253.66 Crore rights issue proceeds into two cancer subsidiaries, enhancing ownership and reducing debt.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was HealthCare Global's revenue in Q2 FY27?
HealthCare Global's consolidated revenue for Q2 FY27 was INR 7,318 Mn, representing a 16% year-over-year growth.
What was HealthCare Global's Adjusted EBITDA in Q2 FY27?
The Adjusted EBITDA for HealthCare Global in Q2 FY27 was INR 1,425 Mn, which is a 17% increase year-over-year, with a margin of 19.7%.
How did patient volumes and ARPP perform for HealthCare Global in Q2 FY27?
HealthCare Global reported a 9% year-over-year growth in patient volumes and a 7% year-over-year increase in Average Revenue Per Patient (ARPP) in Q2 FY27.
How many operational beds did HealthCare Global add in H1 FY27?
HealthCare Global added 25 operational beds in Q2 FY27, contributing to a total of 146 operational bed additions in H1 FY27.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.